日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study

雌激素受体阳性早期乳腺癌患者复发评分26-30的临床结局：一项观察性真实世界队列研究

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00549-8
Rotem, Ofer; Peretz, Idit; Leviov, Michelle; Kuchuk, Iryna; Itay, Amit; Tokar, Margarita; Paluch-Shimon, Shani; Maimon, Ofra; Yerushalmi, Rinat; Drumea, Karen; Evron, Ella; Sonnenblick, Amir; Gal-Yam, Einav; Goldvaser, Hadar; Samih, Yosef; Merose, Rotem; Bareket-Samish, Avital; Soussan-Gutman, Lior; Stemmer, Salomon M
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry

第二原发性乳腺癌：复发评分结果、临床病理特征、辅助治疗和预后——Clalit登记研究的探索性分析

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00586-3
Shachar, Shlomit S; Leviov, Michelle; Yerushalmi, Rinat; Drumea, Karen; Tokar, Margarita; Soussan-Gutman, Lior; Bareket-Samish, Avital; Sonnenblick, Amir; Ben-Baruch, Noa; Evron, Ella; Gal-Yam, Einav Nili; Paluch-Shimon, Shani; Bar-Sela, Gil; Goldvaser, Hadar; Stemmer, Salomon M
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

复发评分指导治疗对N0 ER+乳腺癌患者十年临床疗效的影响

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-019-0137-3
Stemmer, Salomon M; Steiner, Mariana; Rizel, Shulamith; Ben-Baruch, Noa; Uziely, Beatrice; Jakubowski, Debbie M; Baron, Julie; Shak, Steven; Soussan-Gutman, Lior; Bareket-Samish, Avital; Fried, Georgeta; Rosengarten, Ora; Itay, Amit; Nisenbaum, Bella; Katz, Daniela; Leviov, Michelle; Tokar, Margarita; Liebermann, Nicky; Geffen, David B
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏